Metaphase cytogenetics and plasma cell proliferation index for risk stratification in newly diagnosed multiple myeloma

Metaphase cytogenetic abnormalities, plasma cell proliferation index (PCPro), and gain 1q by fluorescence in situ hybridization (FISH) are associated with inferior survival in newly diagnosed multiple myeloma (MM) treated with novel agents; however, their role in risk stratification is unclear in th...

詳細記述

保存先:
書誌詳細
出版年:Blood Adv
主要な著者: Mellors, Patrick W., Binder, Moritz, Ketterling, Rhett P., Greipp, Patricia T., Baughn, Linda B., Peterson, Jess F., Jevremovic, Dragan, Pearce, Kathryn E., Buadi, Francis K., Lacy, Martha Q., Gertz, Morie A., Dispenzieri, Angela, Hayman, Suzanne R., Kapoor, Prashant, Gonsalves, Wilson I., Hwa, Yi L., Fonder, Amie, Hobbs, Miriam, Kourelis, Taxiarchis, Warsame, Rahma, Lust, John A., Leung, Nelson, Go, Ronald S., Kyle, Robert A., Rajkumar, S. Vincent, Kumar, Shaji K.
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Hematology 2020
主題:
Lymphoid Neoplasia
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7252538/
https://ncbi.nlm.nih.gov/pubmed/32442300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019001275
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料